Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keiretsu Capital Co-Investment Fund III is one of several diversified co‑investment venture funds managed by Keiretsu Capital, investing alongside Keiretsu Forum angels in early‑ and growth‑stage companies across sectors including health‑tech and life sciences, but it is an investment vehicle rather than an operating biotech or healthcare company.[1][2][3][4][8][9]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keiretsu Capital Fund III.